As Roche navigates the final impacts of reduced coronavirus sales and a strong Swiss franc, the company maintains its outlook for 2024.

If an e-bike rider has an accident, the injuries are often serious: the pattern of serious head injuries suffered by e-bikers is more similar to that of motorcyclists than cyclists, as a study shows.

The Swiss biotech sector saw record-breaking growth last year. KEYSTONE/Laurent Gillieron The Swiss biotech sector with further records last year.

The MSC Foundation supports Mercy Ships with a new hospital ship set to enhance medical care across Africa.

Two men receive conditional prison sentences for their roles in a large-scale forgery of Covid vaccination certificates.

In response to potential African swine fever threats, the Swiss National Council votes to support meat industry businesses facing closure or losses.

Global food giant Nestlé faces scrutiny over differing sugar levels in its baby food products.

Oculis announces a successful $59 million funding round and its upcoming debut on Nasdaq Iceland.

A EUR 6 million deal between Ascom and Istekki promises to change patient care in Finland with advanced nurse call systems.

Swiss Federal Supreme Court's decision against Basel bar solidifies nitrous oxide ban, setting a nationwide precedent for health and youth protection.

Swiss organic product sales reached CHF 4.075 billion, with consumer preference for organic certification rising despite inflation.

Ypsomed transitions pen needle and BGM business to MTD, channeling investment into expanding Solothurn site and enhancing insulin pump solutions.

CHF 47 Million Proposal: The Federal Council Want Money For Health Insurance Quality and Safety.

Volumina Medical's USD 21 million Series A success spells a new dawn for tissue regeneration.

Hemotune's innovative blood purification platform, HemoSystem, propels into clinical trials with a CHF 14 million Series B2 boost.

Galderma's IPO soars, setting the issue price at 53 francs amid overwhelming demand.

A pioneering study in Zurich, engaging 7500 volunteers, aims to shed light on cannabis consumption and inform future regulations.

Fresh data released by the Swiss Federal Office of Statistics destroys the COVID narrative that a pandemic ripped through Switzerland.